Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-14 · accession 0001209191-22-018820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-15 | 2022-03-14 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $2.73 | +25.0K | 204.8K | +14% | +$68.2K |
| DM | 2022-03-15 | 2022-03-14 | FATE | Valamehr Bahram | Chief R, D Off | S - Sale+OE | $31.07 | -25.0K | 179.8K | -12% | -$776.7K |
| D | 2022-03-15 | 2022-03-14 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $0.00 | -25.0K | 36.2K | -41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | M | A | 25,000 | $2.73 | 204,834 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-14 | S | D | 16,678 | $30.36 | 188,156 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $30.00 to $30.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 5. |
| 3 | Common | Common Stock | 2022-03-14 | S | D | 3,067 | $31.66 | 185,089 | D | — | — | (F3) Represents the weighted average sale price of the shares sold from $31.00 to $31.99 per share. |
| 4 | Common | Common Stock | 2022-03-14 | S | D | 2,195 | $32.49 | 182,894 | D | — | — | (F4) Represents the weighted average sale price of the shares sold from $32.00 to $32.99 per share. |
| 5 | Common | Common Stock | 2022-03-14 | S | D | 2,960 | $33.30 | 179,934 | D | — | — | (F5) Represents the weighted average sale price of the shares sold from $33.00 to $33.91 per share. |
| 6 | Common | Common Stock | 2022-03-14 | S | D | 100 | $34.04 | 179,834 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-03-14 | M | D | 25,000 | $0.00 | 36,156 | D | $2.73 · — to 2027-01-04 | 25,000 Common Stock | (F6) This option is fully vested. |